Evolent Health faces volatility with missed targets and 2024 guidance cuts. Click here for a full investment analysis of EVH ...

Healthcare investors spooked by recent headlines on cuts to Medicare Advantage and a new Justice Department probe of UnitedHealth Group Inc.'s billing practices are worrying about the wrong thing.

Healthcare investors spooked by recent headlines on cuts to Medicare Advantage and a new Justice Department probe of UnitedHealth Group Inc.'s billing practices are worrying about the wrong thing.

Over the past year, many Elevance Health, Inc. ( NYSE:ELV ) insiders sold a significant stake in the company which ...

Shares of Elevance Health Inc. ELV rallied 1.02% to $396.88 Friday, on what proved to be an all-around favorable trading ...

Elevance Health is in financially very healthy shape and is strongly profitable. Click here to read more on the analysis of ...

Elevance Health Inc. closed 30.74% short of its 52-week high of $567.26, which the company reached on September 3rd.

The primary driver behind last 12 months revenue was the Health Benefits segment contributing a total revenue of US$150.3b (85% of total revenue). Notably, cost of sales worth US$127.6b amounted to 72 ...

A GOP budget plan that requires deep cuts to Medicaid spending battered shares of health insurers and hospitals that do big business in the government funded health program. Shares of Centene, t ...

According to Benzinga Pro, Elevance Health's peer group average for short interest as a percentage of float is 5.19%, which means the company has less short interest than most of its peers. Did you ...